Statins, inflammation and cardiovascular risk

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:432 / 432
页数:1
相关论文
共 50 条
  • [1] Statins may decrease cardiovascular disease risk by reducing inflammation
    Bonn, D
    LANCET, 1999, 354 (9175): : 311 - 311
  • [2] Statins and Inflammation in Cardiovascular Disease
    Vogiatzi, Georgia
    Oikonomou, Evangelos
    Siasos, Gerasimos
    Tsalamandris, Sotiris
    Briasoulis, Alexandros
    Androulakis, Emmanuel
    Latsios, George
    Papaioannou, Spyridon
    Tsioufis, Konstantinos
    Tousoulis, Dimitris
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (46) : 7027 - 7039
  • [3] Statins reduce cardiovascular risk
    Mayor, S
    BRITISH MEDICAL JOURNAL, 2002, 325 (7354): : 5 - 5
  • [4] RA—lowering cardiovascular risk with statins
    Justin M. S. Lee
    Robin P. Choudhury
    Nature Reviews Rheumatology, 2010, 6 : 123 - 124
  • [5] STATINS AND CARDIOVASCULAR RISK IN RHEUMATIC DISEASES
    Marasini, B.
    Massarotti, M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (01) : 25 - 30
  • [6] STATINS MODERATE THE EFFECT OF INFLAMMATION ON CORONARY PLAQUE PROGRESSION AND CARDIOVASCULAR DISEASE RISK IN RHEUMATOID ARTHRITIS
    Karpouzas, G.
    Ormseth, S.
    Hernandez, E.
    Budoff, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 281 - 281
  • [7] Inflammation and cardiovascular risk
    Nambi, Vijay
    FUTURE CARDIOLOGY, 2009, 5 (02) : 121 - 123
  • [8] Statins and cardiovascular risk in type 1 diabetes
    Marcovecchio, Loredana
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 14 - 15
  • [9] Effectiveness of statins according to cardiovascular risk in the elderly
    Bezin, J.
    Moore, N.
    Mansiaux, Y.
    Steg, P. G.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 79 - 79
  • [10] View of statins as antimicrobials in cardiovascular risk modification
    Kozarov, Emil
    Padro, Teresa
    Badimon, Lina
    CARDIOVASCULAR RESEARCH, 2014, 102 (03) : 362 - 374